Pemphigus Vulgaris in Old Patient
Pemphigus vulgaris (PV) is a chronic, autoimmune, intraepidermal blistering disease of the skin and mucous membranes. The first clinical manifestation is often the development of intraoral lesions, and later, the lesions involve the other mucous membranes and skin. The etiological factors of this di...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Case Reports in Dentistry |
Online Access: | http://dx.doi.org/10.1155/2021/3946161 |
id |
doaj-34b512a511ae4b91a6e27f42b1bda778 |
---|---|
record_format |
Article |
spelling |
doaj-34b512a511ae4b91a6e27f42b1bda7782021-09-06T00:00:48ZengHindawi LimitedCase Reports in Dentistry2090-64552021-01-01202110.1155/2021/3946161Pemphigus Vulgaris in Old PatientBassel Tarakji0Department of Oral and Maxillofacial Surgery and Diagnostic SciencesPemphigus vulgaris (PV) is a chronic, autoimmune, intraepidermal blistering disease of the skin and mucous membranes. The first clinical manifestation is often the development of intraoral lesions, and later, the lesions involve the other mucous membranes and skin. The etiological factors of this disease still remain unknown, although the presence of autoantibodies is consistent with an autoimmune disease. A 73-year-old man had bullous lesions on gingiva, oral mucosa first, then scalp, trunk, and face. An oral medicine specialist suspects the lesion in differential diagnosis in the first presentation of oral lesions and follows up the patient, and then these bullous lesions presented on the skin. In this article, a patient had received oral prednisolone (80 mg/kg/day) and azathioprine, then tapered oral prednisolone to 40 mg/day, with a reduction of 5 mg/day every three weeks. The patient shows remission of these lesions, and complication of this treatment includes osteoporosis, hyperglycemia, and hypertension.http://dx.doi.org/10.1155/2021/3946161 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Bassel Tarakji |
spellingShingle |
Bassel Tarakji Pemphigus Vulgaris in Old Patient Case Reports in Dentistry |
author_facet |
Bassel Tarakji |
author_sort |
Bassel Tarakji |
title |
Pemphigus Vulgaris in Old Patient |
title_short |
Pemphigus Vulgaris in Old Patient |
title_full |
Pemphigus Vulgaris in Old Patient |
title_fullStr |
Pemphigus Vulgaris in Old Patient |
title_full_unstemmed |
Pemphigus Vulgaris in Old Patient |
title_sort |
pemphigus vulgaris in old patient |
publisher |
Hindawi Limited |
series |
Case Reports in Dentistry |
issn |
2090-6455 |
publishDate |
2021-01-01 |
description |
Pemphigus vulgaris (PV) is a chronic, autoimmune, intraepidermal blistering disease of the skin and mucous membranes. The first clinical manifestation is often the development of intraoral lesions, and later, the lesions involve the other mucous membranes and skin. The etiological factors of this disease still remain unknown, although the presence of autoantibodies is consistent with an autoimmune disease. A 73-year-old man had bullous lesions on gingiva, oral mucosa first, then scalp, trunk, and face. An oral medicine specialist suspects the lesion in differential diagnosis in the first presentation of oral lesions and follows up the patient, and then these bullous lesions presented on the skin. In this article, a patient had received oral prednisolone (80 mg/kg/day) and azathioprine, then tapered oral prednisolone to 40 mg/day, with a reduction of 5 mg/day every three weeks. The patient shows remission of these lesions, and complication of this treatment includes osteoporosis, hyperglycemia, and hypertension. |
url |
http://dx.doi.org/10.1155/2021/3946161 |
work_keys_str_mv |
AT basseltarakji pemphigusvulgarisinoldpatient |
_version_ |
1717780243883753472 |